PLATFORM (6)
Neutraceuticals

6(a) - Addiction Treatment

This pipeline technology is currently under development as per our strategic development plan 2007-09

Canopus BioPharma has developed and is test marketing a neutraceutical supplement which is designed to reduce dependency upon addictive substances. The focus of our research and marketing is targeted at individuals suffering from methamphetamine addiction. The product which we have developed is trademarked RePrieve™

RePrieve™ is a powerful nutraceutical supplement that is quickly absorbed by the body to effectively address the physiological aspects of dependency. By calming the brain, RePrieve™ helps to alleviate the cravings that already exist and block future cravings from forming.

RePrieve™ has been shown to effectively reduce the physical cravings for methamphetamine.

Reprieve's™ ingredients have been documented in peer reviewed scientific publications to act as potent cholinesterase inhibitors.

For more details see our dedicated website:

http://www.bemethfree.com